|
|
Personalized precision dosing of biologic therapies in oncology
|
1R44CA217336-01A1
|
$759,813
|
$759,813
|
MESSMER, BRADLEY
|
ABREOS BIOSCIENCES, INC.
|
|
|
Novel Glyco-tests to Predict Chemoresistance
|
1R43CA213766-01A1
|
$297,480
|
$297,480
|
RAZI, NAHID
|
ACCUDAVA, INC.
|
|
|
Magneto-electronic Sensing of Cancer in Urine
|
1R43CA221535-01
|
$220,000
|
$220,000
|
SANG, LIYUN
|
ACCURE HEALTH, INC.
|
|
|
Endoscopic Flexible Pancreatic Tumor Ablation System with Reduced Force Effector and Specialized Ablation Zone
|
1R43CA225169-01
|
$295,205
|
$295,205
|
SNOOK, KEVIN
|
ACTUATED MEDICAL, INC.
|
|
|
PHOTOACOUSTIC NEEDLE FOR IDENTIFYING TUMOR CONTENT AND MARGINS TO IMPROVE SAMPLING DURING CORE NEEDLE BIOPSY, CAN# 8478658, POP 9/19/2017 - 9/18/2019
|
261201700050C
|
$1,499,895
|
$1,499,895
|
UNKNOWN, UNKNOWN
|
ACTUATED MEDICAL, INC.:1186368
|
|
|
Implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial
|
1R44CA224460-01
|
$299,805
|
$299,805
|
Daunch, William
|
ADVANCED CHEMOTHERAPY TECHNOLOGIES, INC.
|
|
|
Novel Strategies for Precision T-cell Therapies
|
5R01CA198095-02
|
$520,564
|
$520,564
|
ALMO, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Core Support for Cancer Center
|
5P30CA013330-45
|
$3,646,138
|
$145,846
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Colon cancer risk-stratification via optical analysis of rectal ultrastructure
|
5R44CA199667-02
|
$835,665
|
$835,665
|
WALI, RAMESH
|
AMERICAN BIOOPTICS, LLC
|
|
|
Multiplexed In Solution Protein Array (MISPA) for identifying novel protein interactions in cancer and for early detection of immune responses in pathogen-induced cancers
|
5R21CA196442-03
|
$201,623
|
$201,623
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Charge sensitive optical detection for high-throughput study of small molecules
|
5R33CA202834-02
|
$389,677
|
$389,677
|
TAO, NONGJIAN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
AML-MutationCounter, a tool to detect residual and recurrent leukemia
|
1R41CA213690-01
|
$220,087
|
$220,087
|
KAUFMANN, WILLIAM
|
ASYSTBIO LABORATORIES, LLC
|
|
|
SPORE in Lymphoma
|
2P50CA126752-11
|
$3,097,657
|
$371,719
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
(PQ7) In Vivo Cellular Optical Imaging of Esophageal Tumors and Microenvironment
|
5R01CA205431-02
|
$529,795
|
$529,795
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Overcoming Tumor Resistance to Chemotherapy with Multiscale Diffuse and Nonlinear Imaging
|
1F99CA223014-01
|
$41,455
|
$41,455
|
KARROBI, KAVON
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
|
High resolution phase contrast endoscopy
|
5R01CA182939-04
|
$345,234
|
$345,234
|
MERTZ, JEROME
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
|
Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor
|
5R01CA138509-09
|
$368,325
|
$368,325
|
REINHARD, BJOERN
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
|
Engineering personalized micro-tumor ecosystems
|
1U01CA214411-01A1
|
$653,695
|
$653,695
|
KHADEMHOSSEINI, ALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Advancement and Validation of Prostate Diffusion and Spectroscopic MRI
|
5R01CA160902-06
|
$220,860
|
$220,860
|
MAIER, STEPHAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Open source diffusion MRI technology for brain cancer research
|
5U01CA199459-03
|
$368,313
|
$368,313
|
O'DONNELL, LAUREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Recapitulating Ductal Carcinoma on a Chip for Personalized Breast Cancer Therapy
|
5K99CA201603-02
|
$178,200
|
$178,200
|
ZHANG, YU
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Nanosystems Biology Cancer Center
|
5U54CA199090-03
|
$2,403,338
|
$144,200
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
|
Simultaneous Detection of Proteins and Whole Transcriptomes in Single Cells
|
1F32CA213966-01
|
$56,694
|
$56,694
|
XU, ALEXANDER
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S1
|
$118,875
|
$8,321
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S2
|
$60,000
|
$4,200
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S3
|
$200,000
|
$14,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S4
|
$145,821
|
$10,207
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-27
|
$4,895,515
|
$342,686
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Computational Genomic Epidemiology of Cancer (CoGEC) Training Program
|
2T32CA094186-16
|
$302,360
|
$75,590
|
LI, LI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Computerized histologic image predictor of cancer outcome
|
5R01CA202752-02
|
$624,988
|
$624,988
|
MADABHUSHI, ANANT
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Accurate MR-based PET Attenuation Correction for Quantitative Clinical Trials
|
5R01CA196687-03
|
$209,873
|
$209,873
|
MUZIC, RAYMOND
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
FrostBite-BC - A New Thermal Ablation Device for Treating Bladder Cancer
|
1R43CA210761-01A1
|
$308,550
|
$308,550
|
BAUST, J
|
CELL PRESERVATION SERVICES, INC.
|
|
|
FrostBite - A Unique Catheter for Endoscopic Cryoablation
|
2R44CA183265-02A1
|
$1,008,442
|
$1,008,442
|
BAUST, J
|
CELL PRESERVATION SERVICES, INC.
|
|
|
Programmable Individualized NRT Merged With Digital Behavioral Support
|
2R44CA171786-04
|
$1,000,000
|
$1,000,000
|
LEVY, ALAN
|
CHRONO THERAPEUTICS, INC.
|
|
|
CCNY-MSKCC Partnership for Cancer Research Training & Community Outreach(2 of 2)
|
5U54CA132378-10
|
$1,339,371
|
$120,543
|
HUBBARD, KAREN
|
CITY COLLEGE OF NEW YORK
|
|
|
Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Pancreatic Cancers
|
4R44CA210770-02
|
$1,464,585
|
$1,464,585
|
PEREZ, KRISTY
|
CIVATECH ONCOLOGY, INC.
|
|
|
CryoPen: An Innovative Treatment for Cervical Precancer in Low-Resource Setting
|
5UH3CA189883-05
|
$936,421
|
$936,421
|
CREMER, MIRIAM
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
|
Integrated EGFR function in cytokine-driven inflammation and cancer
|
5P01CA062220-22
|
$1,805,475
|
$180,548
|
STARK, GEORGE
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
|
Programmable Probiotics for Cancer
|
5R00CA197649-03
|
$220,680
|
$220,680
|
DANINO, TAL
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
|
Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma
|
5R33CA196470-02
|
$390,115
|
$390,115
|
LIN, QIAO
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
|
Cancer Center Support Grant
|
3P30CA013696-43S1
|
$120,000
|
$3,600
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-43S2
|
$60,000
|
$1,800
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-43S3
|
$118,652
|
$3,560
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-43S4
|
$199,541
|
$5,986
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
5P30CA013696-43
|
$3,792,720
|
$113,782
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
CHRONIC CONVECTION ENHANCED DELIVERY (CED) OF TOPOTECAN FOR GLIOBLASTOMA
|
5R01CA161404-06
|
$532,270
|
$532,270
|
BRUCE, JEFFREY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Super Natural Killer Cells That Target Metastases in the Tumor-Draining Lymph Nodes
|
1R01CA203991-01A1
|
$16,150
|
$8,075
|
KING, MICHAEL
|
CORNELL UNIVERSITY
|
|
|
LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics
|
1R33CA212968-01
|
$371,216
|
$371,216
|
SINGH, ANKUR
|
CORNELL UNIVERSITY
|
|
|
Fast interference-based super-resolution microscope for cancer mechanobiology
|
5R33CA193043-03
|
$364,939
|
$364,939
|
ZIPFEL, WARREN
|
CORNELL UNIVERSITY
|
|
|
Integrated System for FFPE Sample Preparation
|
5R44CA186384-03
|
$264,516
|
$264,516
|
KELLOGG, GREGORY
|
COVARIS, INC.
|
|
Total relevant funding to Bioengineering for this search: $153,597,647
|
